IP Library Assignment 058926/0467
Patent Assignment
Reel/Frame 058926/0467

Change of Name

Recorded: 2022-01-18 Pages: 4
Assignor
LAM THERAPEUTICS, INC.
Executed: 2018-11-26
Assignee
AI THERAPEUTICS, INC.
530 OLD WHITFIELD STREET, GUILFORD, CONNECTICUT, 06437
Covered Property (1)
Inhalable Rapamycin Formulation for the Treatment of Pulmonary Hypertension
Application: 16/728,615 →
Publication: US 2020/0306230
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 18, 2022
From: ARMER, THOMAS; MELVIN, LAWRENCE S., JR.; ROTHBERG, JONATHAN M.; LICHENSTEIN, HENRI
To: LAM THERAPEUTICS, INC.
Reel/Frame 058678/0695 →
Change of Name Oct 4, 2023
From: AI THERAPEUTICS, INC.
To: ORPHAI THERAPEUTICS INC.
Reel/Frame 065120/0663 →
Security Interest Jun 23, 2025
From: ORPHAI THERAPEUTICS INC.
To: ACADIA WOODS PARTNERS, LLC
Reel/Frame 071697/0788 →
Security Interest Feb 18, 2026
From: ORPHAI THERAPEUTICS INC.
To: ACADIA WOODS PARTNERS, LLC, AS AGENT
Reel/Frame 074910/0274 →